SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-042144
Filing Date
2023-11-20
Accepted
2023-11-20 16:59:42
Documents
17
Period of Report
2023-11-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 63682
2 ex3-1.htm EX-3.1 93221
3 ex3-2.htm EX-3.2 87157
4 ex10-1.htm EX-10.1 98496
5 ex3-1_001.jpg GRAPHIC 327253
6 ex3-2_001.jpg GRAPHIC 326783
  Complete submission text file 0001493152-23-042144.txt   1466217

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE invo-20231119.xsd EX-101.SCH 3033
8 XBRL LABEL FILE invo-20231119_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE invo-20231119_pre.xml EX-101.PRE 22371
11 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3308
Mailing Address 5582 BROADCAST COURT SARASOTA FL 34240
Business Address 5582 BROADCAST COURT SARASOTA FL 34240 (978) 878-9505
INVO Bioscience, Inc. (Filer) CIK: 0001417926 (see all company filings)

IRS No.: 204036208 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39701 | Film No.: 231423451
SIC: 3841 Surgical & Medical Instruments & Apparatus